Edwards Lifesciences Corp (EW) Announces Clinical Trial Update
Edwards Lifesciences Corp (EW) provided an update on its clinical development programs.
Clinical Development Highlights:
Drug Program: continue
Diseases/Conditions: an advisory role
Collaboration: CA USA
Updated Timeline: Oct. 30, 2025
🔬 Clinical Development Pipeline (Edwards Lifesciences Corp):
Product
Type
Development Stage
Therapeutic Area
Source
Mitral Valve Repair
DEVICE
Approved
Mitral Valve Regurgitation
ClinicalTrials.gov
J-Valve Transfemoral (TF) System
DEVICE
Approved
Aortic Valve Regurgitation
ClinicalTrials.gov
MITRIS RESILIA Mitral Valve, Model 11400M
DEVICE
Preclinical
Mitral Stenosis
ClinicalTrials.gov
INNOVALVE system
DEVICE
Approved
Mitral Valve Regurgitation (Degenerative or Functional)
ClinicalTrials.gov
The HemoSphere advanced monitoring platform with Acumen HPI software, and Acumen IQ sensor and Acumen IQ cuff
📋 Edwards Lifesciences Corp (EW) - Clinical Trial Update
Filing Date: 2025-10-30
Accepted: 2025-10-30 16:29:32
Event Type: Clinical Trial Update
Event Details:
🔬 Clinical Development Pipeline (Edwards Lifesciences Corp):
💼 Business Developments:
Structured Data: